Novavax (NVAX) Selling, General & Administrative (2010 - 2026)
Novavax (NVAX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-1.52 Mn |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
2.17 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
-7.36 Mn |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
28.78 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
28.78 Mn |
| Dec 31, 2025 |
34.12 Mn |
| Sep 30, 2025 |
31.66 Mn |
| Jun 30, 2025 |
43.61 Mn |
| Mar 31, 2025 |
48.09 Mn |
| Dec 31, 2024 |
78.34 Mn |
| Sep 30, 2024 |
70.75 Mn |
| Jun 30, 2024 |
101.30 Mn |
| Mar 31, 2024 |
86.80 Mn |
| Dec 31, 2023 |
155.24 Mn |
| Sep 30, 2023 |
107.46 Mn |
| Jun 30, 2023 |
93.72 Mn |
| Mar 31, 2023 |
112.53 Mn |
| Dec 31, 2022 |
161.66 Mn |
| Sep 30, 2022 |
122.88 Mn |
| Jun 30, 2022 |
108.16 Mn |
| Mar 31, 2022 |
95.99 Mn |
| Dec 31, 2021 |
84.21 Mn |
| Sep 30, 2021 |
77.79 Mn |
| Jun 30, 2021 |
73.16 Mn |
